{"id":62217,"date":"2025-11-17T19:06:20","date_gmt":"2025-11-17T18:06:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/"},"modified":"2025-11-17T19:06:20","modified_gmt":"2025-11-17T18:06:20","slug":"luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/","title":{"rendered":"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute’s First MRI Unit"},"content":{"rendered":"
\n

\nLandmark gift completes $2.1M campaign, making LuskinOIC the only pediatric facility in downtown Los Angeles with on-site MRI<\/b><\/p>\n

LOS ANGELES–(BUSINESS WIRE)–#CommunityImpact<\/a>–The Everychild Foundation<\/a> has awarded Luskin Orthopaedic Institute for Children (LuskinOIC<\/a>) a transformative $1 million grant to purchase the Institute’s first MRI unit\u2014marking the first seven-figure foundation grant<\/a> in the nonprofit’s 114-year history.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThis extraordinary gift completes LuskinOIC’s $2.1 million campaign to bring state-of-the-art imaging technology to the children it serves. The new MRI unit, designed specifically for pediatric patients, is expected to be installed and operational by 2026 in the newly constructed Everychild Foundation MRI Suite.<\/p>\n

\nOnce installed, the Everychild Foundation MRI will make LuskinOIC the only pediatric orthopaedic facility in downtown Los Angeles with an MRI machine on campus\u2014dramatically improving access for the more than 90% of its patients who are underinsured or rely on Medi-Cal. Currently, families face average wait times of 2.5 months (75 days) to access imaging at off-site locations. The on-site MRI will reduce wait times to 0-2.5 days, and over its 30-year lifespan, will eliminate more than 4.2 million days of waiting for children.<\/p>\n

\n“We’re deeply grateful to the women of Everychild Foundation for this $1 million grant, the capstone that takes our MRI facility all the way to the finish line,” said Dr. Anthony Scaduto, President and CEO of LuskinOIC. “This investment will directly impact the lives of countless children by providing state-of-the-art diagnostic imaging right here where they need it. We’re honored by this partnership and excited about what it means for the future of pediatric care in our community.”<\/p>\n

\n“It is an extraordinary privilege for Everychild Foundation to help LuskinOIC fill this very critical unmet need,” stated Jacqueline Caster, Founder and President of Everychild Foundation. “Without MRI services on premises, their patients have been forced to endure untenable waits to be seen at off-site locations, jeopardizing not just their recovery, but, in some cases, even their lives. No longer! This grant will make an enormous difference for the children of Los Angeles.”<\/p>\n

\nThe partnership underscores LuskinOIC’s century-long mission to expand access to expert orthopaedic care for children, regardless of financial circumstances. Through its alliance with UCLA Health, LuskinOIC serves more than 60,000 patient visits annually and extends its impact globally through pro bono programs in Calexico, Mexicali, and beyond.<\/p>\n

\nLuskinOIC’s $2.1 million MRI campaign was supported by numerous donors and community partners, with the Everychild Foundation’s $1 million commitment serving as the capstone gift that made the project possible. Everychild Foundation’s vision and generosity ensure that the Everychild Foundation MRI Suite will stand as a lasting symbol of healing, innovation, and hope for generations to come.<\/p>\n

\nFor more information, visit <\/b>luskinoic.org<\/b><\/a>, <\/b>support via donation<\/b><\/a>, <\/b>follow us @LuskinOIC<\/b><\/a><\/p>\n

\nTo learn more about Everychild Foundation, please visit everychildfoundation.org<\/a>.<\/b><\/p>\n

\nAbout Luskin Orthopaedic Institute for Children<\/b><\/p>\n

\nFounded in 1911, Luskin Orthopaedic Institute for Children is a nonprofit pediatric orthopaedic hospital and the largest pediatric orthopaedic facility on the West Coast. In partnership with UCLA Health, LuskinOIC serves more than 60,000 patient visits annually, with over 90% of patients covered by Medi-Cal or underinsured. The Institute provides world-class care regardless of families’ ability to pay and operates pro bono clinics serving underserved communities locally and globally. For more information, visit luskinoic.org<\/a>.<\/p>\n

\nAbout Everychild Foundation<\/b><\/p>\n

\nThe Everychild Foundation, founded in 2000, is a Los Angeles-based women’s grant-making and advocacy organization with over 200 members dedicated to easing the suffering of local children, whether due to disease, disability, abuse, neglect, or poverty. Each woman donates an annual contribution, all of which are pooled into a single $1 million grant award to a nonprofit proposing a project that improves the lives of vulnerable children and youth. Including this newest grant, Everychild has now awarded close to $25 million to worthy agencies across Los Angeles County. For more information, visit everychildfoundation.org.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contacts:
\n
Eunha Choi, LuskinOIC
\n
eunhachoi@mednet.ucla.edu<\/a>
213.742.1525<\/p>\n

Monica M. Jaramillo<\/a>, LABEL The Agency<\/a>
mjaramillo@labeltheagency.com<\/a><\/p>\n

Jacqueline Caster
\n
(310) 367-6300
\n
jcaster@everychildfoundation.org<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Landmark gift completes $2.1M campaign, making LuskinOIC the only pediatric facility in downtown Los Angeles with on-site MRI LOS ANGELES–(BUSINESS WIRE)–#CommunityImpact–The Everychild Foundation has awarded Luskin Orthopaedic Institute for Children (LuskinOIC) a transformative $1 million grant to purchase the Institute’s first MRI unit\u2014marking the first seven-figure foundation grant in the nonprofit’s 114-year history. This extraordinary … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62217","6":"format-standard","7":"category-industry"},"yoast_head":"\nLuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute's First MRI Unit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute's First MRI Unit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Landmark gift completes $2.1M campaign, making LuskinOIC the only pediatric facility in downtown Los Angeles with on-site MRI LOS ANGELES–(BUSINESS WIRE)–#CommunityImpact–The Everychild Foundation has awarded Luskin Orthopaedic Institute for Children (LuskinOIC) a transformative $1 million grant to purchase the Institute’s first MRI unit\u2014marking the first seven-figure foundation grant in the nonprofit’s 114-year history. This extraordinary ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-17T18:06:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251117477780\/en\/2218298\/22\/LuskinOIC-Primary-digital-large.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute’s First MRI Unit\",\"datePublished\":\"2025-11-17T18:06:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/\"},\"wordCount\":674,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251117477780\\\/en\\\/2218298\\\/22\\\/LuskinOIC-Primary-digital-large.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/\",\"name\":\"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute's First MRI Unit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251117477780\\\/en\\\/2218298\\\/22\\\/LuskinOIC-Primary-digital-large.jpg\",\"datePublished\":\"2025-11-17T18:06:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251117477780\\\/en\\\/2218298\\\/22\\\/LuskinOIC-Primary-digital-large.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251117477780\\\/en\\\/2218298\\\/22\\\/LuskinOIC-Primary-digital-large.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute’s First MRI Unit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute's First MRI Unit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/","og_locale":"en_US","og_type":"article","og_title":"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute's First MRI Unit - Pharma Trend","og_description":"Landmark gift completes $2.1M campaign, making LuskinOIC the only pediatric facility in downtown Los Angeles with on-site MRI LOS ANGELES–(BUSINESS WIRE)–#CommunityImpact–The Everychild Foundation has awarded Luskin Orthopaedic Institute for Children (LuskinOIC) a transformative $1 million grant to purchase the Institute’s first MRI unit\u2014marking the first seven-figure foundation grant in the nonprofit’s 114-year history. This extraordinary ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-17T18:06:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251117477780\/en\/2218298\/22\/LuskinOIC-Primary-digital-large.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute’s First MRI Unit","datePublished":"2025-11-17T18:06:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/"},"wordCount":674,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251117477780\/en\/2218298\/22\/LuskinOIC-Primary-digital-large.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/","url":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/","name":"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute's First MRI Unit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251117477780\/en\/2218298\/22\/LuskinOIC-Primary-digital-large.jpg","datePublished":"2025-11-17T18:06:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251117477780\/en\/2218298\/22\/LuskinOIC-Primary-digital-large.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251117477780\/en\/2218298\/22\/LuskinOIC-Primary-digital-large.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/luskinoic-awarded-1-million-grant-from-the-everychild-foundation-to-fund-the-institutes-first-mri-unit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LuskinOIC Awarded $1 Million Grant from the Everychild Foundation to Fund the Institute’s First MRI Unit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62217"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62217\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}